Key statistics
Valuation, profitability, and growth metrics
- Market cap
- 2.53B USD
- Enterprise value
- 2.18B USD
- Trailing P/E
- 24.12
- Forward P/E
- 36.14
- Price / sales
- 5.53
- Price / book
- 5.92
- EV / EBITDA
- 175.26
- Beta
- 2.42
- Dividend yield
- —
- Profit margin
- +24.23%
- Return on equity
- +29.49%
- Debt / equity
- 4.52
- Earnings growth
- —
- Revenue growth
- +52.20%
- Free cash flow
- 112.16M USD
- Operating cash flow
- 93.66M USD
- Shares outstanding
- 51.73M
- Sector
- Healthcare
- Industry
- Diagnostics & Research
Updated Sep 2, 2026, 4:06 AM